STTR Phase II: Living Pharmacy for Diabetes and Obesity Treatment — NSF Award to SIMMBION LLC (MD, $1,000,000)
The broader impacts of this Small Business Technology Transfer (STTR) Phase II project could be both substantial and multifaceted, with far-reaching implications across the entire spectrum of healthcare, education, and environmental stewardship. This living pharmacy approach is an innovative and transformative cellular
| Award title | STTR Phase II: Living Pharmacy for Diabetes and Obesity Treatment |
|---|---|
| Award ID | 2413989 |
| Awardee | SIMMBION LLC |
| City | BALTIMORE |
| State | MD |
| Amount obligated | $1,000,000 |
| Principal investigator | Derese Getnet |
| Program | STTR Phase II |
| Start date | 03/15/2025 |
| Abstract | The broader impacts of this Small Business Technology Transfer (STTR) Phase II project could be both substantial and multifaceted, with far-reaching implications across the entire spectrum of healthcare, education, and environmental stewardship. This living pharmacy approach is an innovative and transformative cellular factory method of administering treatments and managing chronic diseases by maintaining steady-state drug levels over long periods of time without the need for frequent dosing. By |
| Source | NSF Awards |
$799/mo
Try NSFGrants →